| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
195,811,000 |
| Market
Cap: |
1.32(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.08 - $6.74 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile ADMA Biologics is an end-to-end commercial biopharmaceutical company focused on manufacturing, marketing and developing plasma-derived biologics for the treatment of immunodeficient patients at risk for infectious diseases. Co.'s products include: BIVIGAM (Immune Globulin Intravenous, Human), an Intravenous Immune Globulin (IVIG) product indicated for the treatment of Primary Humoral Immunodeficiency (PI); ASCENIV (Immune Globulin Intravenous, Human – slra 10% Liquid), an IVIG product indicated for the treatment of PI; and Nabi-HB (Hepatitis B Immune Globulin, Human), which is indicated for the treatment of acute exposure to blood containing HBsAg and other listed exposures to Hepatitis B.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
155,000 |
191,958 |
| Total Buy Value |
$0 |
$0 |
$579,644 |
$685,344 |
| Total People Bought |
0 |
0 |
2 |
4 |
| Total Buy Transactions |
0 |
0 |
2 |
5 |
| Total Shares Sold |
1,500,000 |
1,500,000 |
4,083,538 |
4,083,538 |
| Total Sell Value |
$9,143,159 |
$9,143,159 |
$19,811,348 |
$19,811,348 |
| Total People Sold |
1 |
1 |
4 |
4 |
| Total Sell Transactions |
5 |
5 |
11 |
11 |
| End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Grossman Adam S |
President and CEO |
• • – |
2023-12-31 |
4 |
D |
$4.52 |
$104,218 |
D/D |
(23,057) |
2,231,310 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2023-09-30 |
4 |
D |
$3.58 |
$67,010 |
D/D |
(18,718) |
2,254,367 |
|
- |
|
| Lenz Brian |
EVP, CFO |
• • – |
2023-09-30 |
4 |
D |
$3.58 |
$54,659 |
D/D |
(15,268) |
766,744 |
|
- |
|
| Grossman Jerrold B |
|
• • – |
2023-08-30 |
4 |
B |
$3.71 |
$482,144 |
D/D |
130,000 |
443,265 |
0.01 |
39% |
|
| Kwon Young |
|
• • – |
2023-08-24 |
4 |
B |
$3.90 |
$97,500 |
D/D |
25,000 |
277,401 |
0.01 |
14% |
|
| Fong Bryant |
|
• • – |
2023-08-22 |
4 |
S |
$3.87 |
$5,544,737 |
I/I |
(1,433,304) |
0 |
|
-17% |
|
| Grossman Adam S |
President and CEO |
• • – |
2023-08-18 |
4 |
S |
$4.15 |
$1,038,350 |
D/D |
(250,000) |
2,273,085 |
|
-10% |
|
| Grossman Adam S |
President and CEO |
• • – |
2023-08-16 |
4 |
S |
$4.39 |
$13 |
D/D |
(3) |
2,523,085 |
|
5% |
|
| Lenz Brian |
EVP, CFO |
• • – |
2023-08-16 |
4 |
S |
$4.45 |
$793,400 |
D/D |
(178,184) |
782,013 |
|
5% |
|
| Grossman Adam S |
President and CEO |
• • – |
2023-08-15 |
4 |
D |
$4.61 |
$7,329,840 |
D/D |
(1,589,987) |
2,523,088 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2023-08-15 |
4 |
S |
$4.54 |
$2,318,959 |
D/D |
(510,469) |
4,113,075 |
|
9% |
|
| Grossman Adam S |
President and CEO |
• • – |
2023-08-15 |
4 |
OE |
$1.67 |
$6,536,448 |
D/D |
2,100,459 |
4,623,544 |
|
- |
|
| Lenz Brian |
EVP, CFO |
• • – |
2023-08-15 |
4 |
D |
$4.61 |
$2,909,270 |
D/D |
(631,078) |
960,197 |
|
- |
|
| Lenz Brian |
EVP, CFO |
• • – |
2023-08-15 |
4 |
OE |
$1.67 |
$2,514,363 |
D/D |
809,262 |
1,591,275 |
|
- |
|
| Lenz Brian |
EVP, CFO |
• • – |
2023-08-15 |
4 |
S |
$4.60 |
$972,730 |
D/D |
(211,578) |
782,013 |
|
9% |
|
| Grossman Adam S |
President and CEO |
• • – |
2023-06-30 |
4 |
D |
$3.69 |
$73,988 |
D/D |
(20,051) |
2,523,085 |
|
- |
|
| Lenz Brian |
EVP, CFO |
• • – |
2023-06-30 |
4 |
D |
$3.69 |
$56,339 |
D/D |
(15,268) |
993,591 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2023-03-07 |
4 |
D |
$3.40 |
$80,264 |
D/D |
(23,607) |
2,560,992 |
|
- |
|
| Lenz Brian |
EVP, CFO |
• • – |
2023-03-07 |
4 |
D |
$3.40 |
$57,681 |
D/D |
(16,965) |
1,024,327 |
|
- |
|
| Grossman Adam S |
President and CEO |
• • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
573,695 |
2,584,599 |
|
- |
|
| Fong Bryant |
|
• • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
25,815 |
59,901 |
|
- |
|
| Demski Martha J |
|
• • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
I/I |
25,815 |
56,601 |
|
- |
|
| Kwon Young |
|
• • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
25,815 |
252,401 |
|
- |
|
| Guiheen Lawrence P. |
|
• • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
25,815 |
129,901 |
|
- |
|
| Elms Steve |
|
• • – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
25,815 |
52,401 |
|
- |
|
222 Records found
|
|
Page 2 of 9 |
|
|
0.07 (1.05%) 
